title: Haemostasis in ischaemic stroke and vascular dementia.
abstract: Abnormalities of coagulation and fibrinolysis may play an important role in the pathogenesis of ischaemic stroke and vascular dementia. We aimed to determine whether haemostatic function is altered in acute recent-onset or chronic ischaemic cerebrovascular disease. We studied consecutive patients with ischaemic stroke (n = 74) and vascular dementia (n = 42) compared with healthy controls (n = 40) in a case-control study. The ischaemic stroke group was assessed twice, 3-10 days after the acute stroke and at 1-3 months. Fibrinogen, fibrin D-dimer (marker of fibrin turnover) and von Willebrand factor (vWF) (marker of endothelial disturbance) were elevated acutely (P < 0.0001) and in the convalescent phase after ischaemic stroke (P < 0.0001, P < 0.0001, and P < 0.01 respectively, compared with controls). Similar results were seen in the vascular dementia group. Stepwise multivariate regression analyses showed that cerebrovascular disease correlated independently with fibrinogen (P < 0.001) and fibrin D-dimer levels (P < 0.001), while vWF correlated independently with electrocardiograph evidence of ischaemic heart disease (P = 0.004). Changes between acute and convalescent phases in ischaemic stroke were slightly inconsistent. However, in the acute stage there were tendencies for fibrinogen, D-dimer and vWF to be increased, and factor VIII was significantly higher. Abnormalities of haemostasis, including increased fibrin turnover and endothelial disturbance, are found in both acute and chronic cerebral ischaemia. Many of these patients have co-existent ischaemic heart disease and this may contribute to some of these changes. Acute ischaemic stroke is associated with transient changes in haemostatic factors; however, most abnormalities persist into the convalescent phase, and are also demonstrable in subjects with vascular dementia.
authors.affiliation: Academic Section of Geriatric Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK. d.j.scott@clinmed.gla.ac.uk
authors.forename: D J
authors.initials: DJ
authors.lastname: Stott
authors.forename: E
authors.initials: E
authors.lastname: Spilg
authors.forename: A M
authors.initials: AM
authors.lastname: Campbell
authors.forename: A
authors.initials: A
authors.lastname: Rumley
authors.forename: M A
authors.initials: MA
authors.lastname: Mansoor
authors.forename: G D
authors.initials: GD
authors.lastname: Lowe
mesh_terms: D000210:Acute-Phase Reaction / Q000097:blood; D000368:Aged; D002545:Brain Ischemia / Q000097:blood* / Q000209:etiology; D016022:Case-Control Studies; D015140:Dementia, Vascular / Q000097:blood* / Q000209:etiology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000097:blood* / Q000209:etiology; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D014841:von Willebrand Factor; D005340:Fibrinogen